PMC:7228307 / 37951-38257 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"640","span":{"begin":301,"end":305},"obj":"Gene"},{"id":"641","span":{"begin":131,"end":135},"obj":"Gene"}],"attributes":[{"id":"A640","pred":"tao:has_database_id","subj":"640","obj":"Gene:2213"},{"id":"A641","pred":"tao:has_database_id","subj":"641","obj":"Gene:2213"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The experience of three decades of clinical use of mAbs taken together with our extensive, albeit incomplete, knowledge of IgG and FcγR structure and immunobiology provides a war chest for the innovative development of new and highly potent mAbs through the manipulation of their interaction with the FcγR."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T341","span":{"begin":123,"end":126},"obj":"Body_part"},{"id":"T342","span":{"begin":179,"end":184},"obj":"Body_part"}],"attributes":[{"id":"A341","pred":"fma_id","subj":"T341","obj":"http://purl.org/sig/ont/fma/fma62872"},{"id":"A342","pred":"fma_id","subj":"T342","obj":"http://purl.org/sig/ont/fma/fma9576"}],"text":"The experience of three decades of clinical use of mAbs taken together with our extensive, albeit incomplete, knowledge of IgG and FcγR structure and immunobiology provides a war chest for the innovative development of new and highly potent mAbs through the manipulation of their interaction with the FcγR."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T21","span":{"begin":179,"end":184},"obj":"Body_part"}],"attributes":[{"id":"A21","pred":"uberon_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/UBERON_0001443"}],"text":"The experience of three decades of clinical use of mAbs taken together with our extensive, albeit incomplete, knowledge of IgG and FcγR structure and immunobiology provides a war chest for the innovative development of new and highly potent mAbs through the manipulation of their interaction with the FcγR."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T692","span":{"begin":131,"end":133},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T693","span":{"begin":173,"end":174},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T694","span":{"begin":179,"end":184},"obj":"http://www.ebi.ac.uk/efo/EFO_0000965"},{"id":"T695","span":{"begin":301,"end":303},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"}],"text":"The experience of three decades of clinical use of mAbs taken together with our extensive, albeit incomplete, knowledge of IgG and FcγR structure and immunobiology provides a war chest for the innovative development of new and highly potent mAbs through the manipulation of their interaction with the FcγR."}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"641","span":{"begin":131,"end":135},"obj":"Gene"}],"attributes":[{"id":"A641","pred":"pubann:denotes","subj":"641","obj":"Gene:2213"}],"text":"The experience of three decades of clinical use of mAbs taken together with our extensive, albeit incomplete, knowledge of IgG and FcγR structure and immunobiology provides a war chest for the innovative development of new and highly potent mAbs through the manipulation of their interaction with the FcγR."}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T216","span":{"begin":0,"end":306},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The experience of three decades of clinical use of mAbs taken together with our extensive, albeit incomplete, knowledge of IgG and FcγR structure and immunobiology provides a war chest for the innovative development of new and highly potent mAbs through the manipulation of their interaction with the FcγR."}

{"project":"LitCovid-sample-PD-UBERON","denotations":[{"id":"T21","span":{"begin":179,"end":184},"obj":"Body_part"}],"attributes":[{"id":"A21","pred":"uberon_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/UBERON_0001443"}],"text":"The experience of three decades of clinical use of mAbs taken together with our extensive, albeit incomplete, knowledge of IgG and FcγR structure and immunobiology provides a war chest for the innovative development of new and highly potent mAbs through the manipulation of their interaction with the FcγR."}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T340","span":{"begin":123,"end":126},"obj":"Body_part"},{"id":"T341","span":{"begin":179,"end":184},"obj":"Body_part"}],"attributes":[{"id":"A340","pred":"fma_id","subj":"T340","obj":"http://purl.org/sig/ont/fma/fma62872"},{"id":"A341","pred":"fma_id","subj":"T341","obj":"http://purl.org/sig/ont/fma/fma9576"}],"text":"The experience of three decades of clinical use of mAbs taken together with our extensive, albeit incomplete, knowledge of IgG and FcγR structure and immunobiology provides a war chest for the innovative development of new and highly potent mAbs through the manipulation of their interaction with the FcγR."}

{"project":"LitCovid-sentences","denotations":[{"id":"T216","span":{"begin":0,"end":306},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The experience of three decades of clinical use of mAbs taken together with our extensive, albeit incomplete, knowledge of IgG and FcγR structure and immunobiology provides a war chest for the innovative development of new and highly potent mAbs through the manipulation of their interaction with the FcγR."}